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Abstract 
Royal jelly is a bee-derived product with potent antioxidative and many other biological properties. The present 
study was designed to examine the effect of Royal jelly (RJ) on brain damage induced by hypoxia-ischemia in 
mice. Mice were given RJ orally one dose / day (0-300 mg/kg body wt./ day for 13 consecutive days, survival 
time of mice were recorded following decapitation (Total brain ischemia model; model-1) and i. p. injection of 
NaNO2 to induce brain hypoxia (model-2).  RJ in the dose of 75 mg/kg body wt. /day for 13 consecutive days 
(RJ75) showed no significant effect in both experimental models compared to control animals. However, the 
doses of 150mg/kg body wet/day (RJ150) and 300mg/kg body wet. /day (R300) showed potent pharmacological 
activity in both experimental models. In model-1 the survival time of mice by decapitation was significantly 
(p<0.001) prolonged after administration of RJ150, but was significantly (p<0.001) shortened after administration 
of RJ300 compared to control groups. However, in model-2, 3 out of 10 mice with RJ150 survived after i.p. 
NaNO2-induced hypoxia, an incident which was not observed in control mice that received only i.p. NaNO2. 
The RJ150-treated animals that died showed a significant (p<0.001) prolongation in survival time after NaNO2-
induced hypoxia compared to control animals.  
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On the other hand, the R300 -treated animals showed a significantly (p<0.001) shortened of survival time after 
i.p.NaNO2-induced hypoxia compared to control group. Taken together; the results of this study shows that RJ 
may protect or aggravate brain damage induced by hypoxia-ischemia in mice, depending on its dose.  
Keywords:  Royal jelly; brain hypoxia; brain ischemia; sodium dinitrate; mice. 
1. Introduction  
The brain is extremely sensitive to both reductions in blood flow and deficiency in the amount of oxygen supply 
i.e. the brain significantly depends on uninterrupted delivery of oxygen and glucose, more than any other organ 
[1]. This is due to brain’s high-energy demand, together with its incomplete ability to store energy [2]. The 
major pathogenic mechanism causing neurological injure resulting from ischemia and/or hypoxia is due to the 
deficiency of the glucose and oxygen supply to the brain, initiating a cascade of biochemical events leading to 
cell dysfunction and eventually to cell death [3,4].  Accumulating evidences show that oxidative stress, which is 
an imbalance between free radicals and antioxidant system, is the main biochemical event leading to brain 
damage [5, 6, 7]. Enhanced formation of reactive oxygen species (ROS) reduces membrane fluidity through 
lipid peroxidation resulting in cell injury [8]. As oxidative stress is considered to be an early feature in the 
procedure of brain damage after ischemia or hypoxia, this makes it attractive target for neuroprotective 
strategies [9]. Therefore, inhibition of free radical damage with antioxidants and free radical scavengers could 
be a viable intervention to protect neuronal damage after ischemia and hypoxia [5]. These antioxidants and free 
radical scavengers can be either synthetic or natural ones. However, it has been showed that inhibition of the 
formation of reactive oxygen species by synthetic antioxidants is not always completes [9, 10, 11, 12]. In 
addition, antioxidant must be safe and nontoxic, and must easily penetrate the blood–brain barrier.  
Royal jelly (RJ), a bee-derived product, posses potent antioxidative properties. The antioxidant actions of this 
product have been extensively verified, and previous studies have revealed that RJ can ameliorate a variety of 
disease processes in different model [13, 14, 15, 16, 17, 18, 19]. RJ inhibits lipid peroxidation and protein 
oxidation by acting as a scavenger [14, 15, 16, 20].  To date, no study has investigated the neuroprotective 
effects of RJ in models of ischemia or hypoxia-induced brain damage. Therefore, this study was carried out to 
determine the neuroprotective effects of RJ in two experimental models i.e. complete brain ischemia and brain 
hypoxia induced by NaNO2.     
2. Materials and Methods 
2.1. Materials  
Egyptian RJ was purchased from Wadii Alnaheel Company, Hail, Saudi Arabia, and was stored at -20˚C until 
used. Sodium dinitrate was obtained from Sigma (St. Louis, MO, USA). Male Swiss albino mice, 20-25 g, were 
obtained from King Saud University, Riyadh, Saudi Arabia. The animals were housed in colony cages with free 
access to standard commercial food and tap water. The experiments started after 7- day acclimatization to 
standardized laboratory conditions (22-24˚C and a 12-hour light/dark cycle). The protocol of this study was 
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approved by the ethics board of animal experiments, University of Hail. All experimental procedures were 
conducted in accordance with the guidance of care and use of laboratory animals. 
2.2. Complete brain ischemia & Brain hypoxia induced by NaNO2.  
The method described by Xiao-Dong et al was to induce complete brain ischemia & brain hypoxia [21].  Mice 
were randomly assigned to 4 main groups consisting of 20 animals each according to their experimental 
treatment. The three experimental groups (RJ300, RJ150 and RJ75) received royal jelly dissolved in normal saline 
at 300, 150, or 75 mg/kg/day orally respectively. The control group received only normal saline. This procedure 
was repeated for 13 days. Standard diet was given to during this period but no food was allowed to the mice 
during night (a period of 12 hours), only water was allowed. Twenty –four hours after the final royal jelly and 
normal saline treatment, every group was divided into two subgroups A and B consisting of 10 mice each. All 
animals of A subgroups were killed by decapitation to induce complete brain ischemia and the time from 
decapitation to breath stop was recorded. The animals of B subgroups were given a single dose of NaNO2 (250 
mg/kg) i.p. to induce brain hypoxia and the survival time of the mouse was recorded.  
3. Results 
None of the animals in the control and experimental groups died during the experiment.  The effects of RJ on 
mouse complete brain ischemia are presented in Fig.1. The effects of this substance on mouse brain hypoxia are 
shown in Fig.2.   
 
 
                      Fig.1. Effects of RJ on the survival time (in seconds) of mice following decapitation 
3.1. Effects of RJ on mouse complete brain ischemia induced by decapitation 
In order to test the effects of RJ pre-treatments against complete brain ischemia induced by decapitation, RJ was 
administered to mice in three increasing doses (75mg/day, 150mg/day, and 300mg/day) for 13 consecutive days 
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[21].  As shown in Fig.1 RJ in the dose of 75mg/kg/day prolonged the duration of breathe of mouse from 17.1 
seconds (for control group) to 18.1 seconds, which was not statistically significant.  The dose of RJ of 
150mg/kg/day resulted in the significant (P< 0.001) prolonged this value to 24.4 seconds. In contrast, RJ in the 
dose of 300 mg/kg/day leads to significant (P<0.001) shorten of the duration of breath of mouse to 6.1 seconds. 
3.2. Effects of RJ on mouse brain hypoxia induced by NaNO2 
Figure. 2. shows effects of RJ pre-treatments against brain-hypoxia induced by NaNO2 in royal jelly treated 
mice.  RJ in the dose of 75mg/kg/day for 13 consecutive days led to prolongation of the survival time of mouse 
after injection of NaNO2, form 32.86 minutes (for control group) to33.4 minutes , which was not statistically 
significant. The dose of 150mg/kg/day RJ protected 3 animals out of 10 from death. The dead animals of this 
group showed significant (P<0.001) prolongation of survival time to 39.3 minutes. Conversely, RJ in the dose of 
300 mg/kg/day resulted in significant (P<0.001) shortening of survival time of the animals after giving the 
NaNO2 to 26.0 minutes.                     
 
Fig.2. Effects of RJ on the survival time (in minutes) of mice following i.p. NaNO2 
3.3. Statistical analyses 
The SPSS version 15 was used for data analysis. Data were expressed as mean ± SD. Mean values were 
compared using unpaired t-test. P-values less than 0.05 were considered significant. 
4. Discussion 
The current study revealed the neuroprotective effects of RJ, which was given to the mice in the dose of 
150mg/kg/day for 13 consecutive days, against brain damage caused by both decapitation induced ischemia as 
well as sodium nitrite induced hypoxia. To my knowledge, this effect has not been previously observed. These 
findings indicated that RJ pretreatment increased survival rates of animals after hypoxia as well as after 
ischemia, demonstrating that RJ may be a promising agent to prevent hypoxia–ischemia brain damage in 
patients in a clinical setting. These findings may have extreme importance, because ischemic damage is main 
341 
 
 International Journal of Sciences: Basic and Applied Research (IJSBAR) (2015) Volume 19, No  2, pp 338-346  
cause of death and disability over the world and, there is no definite reasonable and effective treatment for this 
disorder yet [22, 23].  
These results agree with recent findings that RJ in the dose of 50 mg/kg per day for 7 days protected radiation-
induced brain damages in rats [24]. The results of this study are also in concordance with the previous report 
which described the neuroprotective effect of 100 mg/ kg RJ on traumatic spinal cord injury- induced neuronal 
damage in rabbits [25]. 
 A surprising observation in the present study was the detection of harmful effect of RJ in the dose of 
300mg/kg/day for 13 consecutive days, against brain damage for both ischemic and hypoxic animals. It turned 
out that this dose of RJ significantly shortened survival rates of both ischemic and hypoxic animals. However, it 
is known from the literature that the toxic dose of RJ is 3000mg/kg/day in mice and rats [30].  Moreover, RJ in 
the dose of 300 mg/kg/day or more showed anti oxidative effects and thus, many benefit protective effects in 
other organs than brain [17, 26, 27, 28, 29], despite the fact that the main constituents of royal jelly (water, 
protein, sugars, lipids and mineral salts) are relatively constant when comparing different colonies, bee races 
and time (Although they occur with notable variations) [30].   Therefore, further investigations are needed to 
determine safe doses of this product when used clinically in those suffering from ischemic and/or hypoxic 
disorders. The finding of this study that RJ exhibits neuroprotective may be attributed to antioxidant and radical 
scavenging activity of this product. On the other hand, namely the deleterious effect of RJ against ischemic and 
hypoxic brain at 300 mg /kg body wet. /day cannot be easily explained based on the available literature data. RJ 
has been reported to aid the differentiation of all types of brain cells including neurons from cultured neural 
stem/progenitor cells [31] and facilitate in vivo neurogenesis in the hippocampal dentate gyrus [32]. In addition, 
it has been demonstrated that RJ may play neurotrophic and/or neuroprotective roles in the adult mouse brain 
via expression of glial cell line-derived neurotrophic factor, a potent neurotrophic factor acting in the brain [31, 
33, 34]. RJ has also been shown to assist restoration of the cognitive ability in trimethyltin-intoxicated mice 
[32]. Thus, RJ may protect brain damage-induced by ischemia and/or hypoxia through multiple mechanisms.  
The deleterious effect of chronic pretreatment of animals with RJ300 may involve many mechanisms. It has 
been shown that acidosis is one of the factors that aggravate ischemic brain injury during cerebral ischemia [35, 
36].  Results from other studies in the rat and mice stroke models induced by transient middle cerebral artery 
occlusion proposed that activation of acid-sensing channels (ASICs) during cerebral ischemia contributed to 
ischemic brain injury [37, 4]. Activation of the ASICs by the lower extracellular pH as a result of acidosis 
allows influx of calcium ions through the channels into the neuronal cells; the intracellular calcium-overload 
induces cell injury and cell death [4, 38]. Meanwhile, the pH of RJ is 3.6 to 4.2 [30]. 
Therefore, aggravation of brain damage induced by large doses of RJ pretreatment could be ascribed to acidosis 
of extracellular fluid due to RJ acidity. In view of the above, it may be hypothesized that RJ (or its more acidic 
components) in brain possess two opposite mechanisms i.e.; neuroprotective effects via activation of the 
antioxidant way (and other mechanisms) along with enhanced neuronal damage mechanism through decreasing 
the pH of the extracellular fluid. The higher the RJ dose the lower the pH in brain extracellular fluid, the more 
predominate the second harmful mechanism.    
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5. Conclusion  
 Based on the findings of this study it may be suggested that RJ possesses opposite effects depending on its 
dose, i.e. either protect or aggravate brain damage induced by hypoxia-ischemia in mice. Further studies on 
these effects of RJ may help in designing optimal effective and safe doses for better therapeutic regimes for both 
ischemia and hypoxia injury. Additional investigations are also of utmost importance to find out the mechanism 
of detrimental action of large doses of RJ against brain damage induced by ischemia and/or hypoxia.   
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